Insider Brief
- Microgravity may accelerate brain cell growth, as shown by a study using neural organoids aboard the ISS, raising concerns about astronauts’ neurological health during extended space missions.
- Potential astronaut risks include rapid neural aging and altered responses to stimuli, suggesting the need for pre-mission screenings and real-time monitoring to manage cognitive health during space travel.
- Biomanufacturing in space may benefit, as accelerated cell maturation could expedite pharmaceutical testing and tissue engineering, creating new opportunities for space-based medical research and innovation.
As the space industry contemplates longer, more extensive missions, researchers are also investigating how the those missions might affect the health of astronauts who embark on those assignments.
In a recent study that examined the natural growth of neural organoids in space, a team of researchers from the New York Stem Cell Foundation Research Institute found that microgravity significantly accelerates the maturation of brain cells. Conducted aboard the International Space Station (ISS), the research offers several implications for astronaut health, as well as suggests ways this may benefit space-based biomedical research in the future, according to the study, which was published in Stem Cells Translational Medicine.
Faster Maturation
The researchers relied on human-induced pluripotent stem cell (iPSC)-derived neural organoids, which are lab-grown models that mimic early brain development. These organoids were maintained aboard the ISS for an extended period without replacing or replenishing the nutrient solution, simulating a sustainable environment for long-term cell study in space. The space-based organoids were compared to those grown under standard conditions on Earth to identify differences in growth patterns and gene expression.
Researchers observed that the space-grown organoids exhibited faster maturation than their Earth-based counterparts. Genetic analysis revealed a lower expression of cell proliferation markers and a higher expression of genes associated with cell differentiation and maturation. This finding indicates that the microgravity environment fosters accelerated neural development, which could have dual implications: identifying potential risks for human health during space missions, while also showing that advanced research in space is possible.
Health Implications for Astronauts
The accelerated maturation of brain cells in microgravity raises questions about how prolonged exposure to space conditions might affect astronauts’ neurological health. Previous research has shown that space travel can lead to structural changes in the brain, including shifts in gray matter and fluid distribution. The findings from this study support the idea that microgravity could amplify these effects by altering neural cell growth and maturation.
The presence of microglia in the organoids — immune cells essential for maintaining brain health — adds another dimension to these implications. Changes in microglial function could influence how astronauts’ brains respond to inflammation or stress during extended missions. If microgravity prompts rapid neural maturation, there might be a risk of accelerated neural aging or altered responses to environmental stimuli. This would necessitate thorough pre-mission screenings and real-time monitoring of brain health during missions to detect early signs of cognitive or neurological changes.
Space Industry Implications
The implications of this study extend beyond astronaut health and into broader space industry applications. The demonstrated ability to culture complex organoids sustainably in microgravity opens pathways for biomanufacturing and medical research conducted in space. Microgravity’s influence on cellular maturation could be harnessed to accelerate pharmaceutical testing and tissue engineering, potentially expediting drug development processes and advancing regenerative medicine.
Additionally, understanding how microgravity impacts neural development could inform the design of future spacecraft and habitats to include technologies or environments that mitigate potential neurological risks. For instance, innovations could be introduced to regulate neural cell growth, manage cognitive health, and prevent issues stemming from accelerated maturation, such as neurodegenerative conditions.
Limitations of the Study
The study’s limitations include its preclinical nature and reliance on organoid models, which, while useful, may not entirely replicate the complexity of the human brain. Additionally, the research was conducted in a controlled environment aboard the ISS, where other variables — such as radiation exposure — were minimal compared to what might be encountered on deep-space missions. This means that while the accelerated maturation can be attributed to microgravity, the full impact of space radiation on neural development remains unexplored in this context.
The use of organoids derived from individuals with primary progressive multiple sclerosis (PPMS) and Parkinson’s disease adds another layer of complexity. While it offers insight into how microgravity could influence disease-specific neural responses, it also introduces variables that might not apply to a fully healthy population. Future research should consider expanding the sample to include organoids representing different demographics and health conditions to achieve more generalized findings.
The findings — and the limitations — point to several avenues for future research. One focus should be on developing comprehensive countermeasures to monitor and protect astronaut brain health during long missions. Potential solutions could include targeted neuroprotective strategies, such as tailored exercise regimens, pharmaceutical interventions, or controlled environmental stimuli designed to simulate gravity’s effects on neural cells.
Further exploration into the combined impact of microgravity and radiation exposure is essential, especially for missions beyond low Earth orbit. Conducting similar experiments on spacecraft designed for lunar or Mars missions could provide a fuller understanding of how long-term exposure to the space environment affects human health. Additionally, using quantum computing and AI to model potential impacts on the human brain could help simulate and predict outcomes, offering a proactive approach to safeguarding astronaut well-being.
The space industry might also leverage these insights to refine biomanufacturing processes. For instance, microgravity’s acceleration of neural maturation could be utilized in developing organoids or tissues for clinical use, where rapid development is advantageous. Such applications could attract partnerships between space agencies and biotechnology firms focused on cutting-edge medical solutions.
Scientists from Scripps Research, Space Tango and the National Stem Cell Foundation also worked on the study.
The National Stem Cell Foundation supported this research.
Matt Swayne
With a several-decades long background in journalism and communications, Matt Swayne has worked as a science communicator for an R1 university for more than 12 years, specializing in translating high tech and deep tech for the general audience. He has served as a writer, editor and analyst at The Space Impulse since its inception. In addition to his service as a science communicator, Matt also develops courses to improve the media and communications skills of scientists and has taught courses.
Share this article:
